학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 32건 | 목록 1~20
Academic Journal
Wei X; Revolution Medicines (United States) Redwood City, CA United States.; Blaj C; Revolution Medicines (United States) Redwood City, CA United States.; Ali Al-Radhawi M; Revolution Medicines (United States) Redwood City, CA United States.; Lai LP; Revolution Medicines (United States) Redwood City, CA United States.; Maldonato BJ; Revolution Medicines (United States) Redwood City, CA United States.; Yang YC; Revolution Medicines (United States) Redwood City, CA United States.; Seu L; Revolution Medicines (United States) Redwood City, CA United States.; Gundlapalli H; Revolution Medicines (United States) Redwood City United States.; Jiang L; Revolution Medicines (United States) Redwood City, CA United States.; Moreno Ayala MA; Revolution Medicines (United States) Redwood City, CA United States.; Spradlin JN; Revolution Medicines (United States) Redwood City, CA United States.; Garrick B; Revolution Medicines (United States) Redwood City, CA United States.; Cai S; Revolution Medicines (United States) Redwood City, CA United States.; Salmon A; Revolution Medicines (United States) Redwood City, CA United States.; Pham A; Revolution Medicines (United States) Redwood City, CA United States.; Bredeson S; Revolution Medicines (United States) Redwood City, CA United States.; Liang R; Revolution Medicines (United States) Redwood City, CA United States.; Helland C; Revolution Medicines (United States) Redwood City, CA United States.; Evans JW; Revolution Medicines (United States) Redwood City, CA United States.; Labrecque MP; Revolution Medicines (United States) Redwood City, California United States.; Yu X; Revolution Medicines (United States) Redwood City, CA United States.; Song AHJ; Revolution Medicines (United States) Redwood City, CA United States.; Dinglasan N; Revolution Medicines Redwood City, CA United States.; Tran L; Revolution Medicines (United States) Redwood City, CA United States.; Kumamoto A; Revolution Medicines (United States) Redwood City, CA United States.; Grigoryan L; Revolution Medicines (United States) Redwood City, CA United States.; Malliri A; University of Manchester United Kingdom.; Brown KD; The Christie NHS Foundation Trust Manchester United Kingdom.; Carter M; The Christie NHS Foundation Trust Manchester United Kingdom.; Simpson KL; Cancer Research UK Manchester Institute Alderley Park, Chesire United Kingdom.; Crosbie PA; University of Manchester Manchester United Kingdom.; Galvin M; Cancer Research UK Manchester Institute Manchester United Kingdom.; Chang S; Revolution Medicines (United States) Redwood City, CA United States.; Huang Y; Revolution Medicines (United States) Redwood City, CA United States.; Tovbis Shifrin N; Revolution Medicines (United States) Redwood City, CA United States.; Pechuan-Jorge X; Revolution Medicines (United States) Redwood City, CA United States.; Raghulan R; Revolution Medicines (United States) Redwood City, CA United States.; Zhuang Y; Revolution Medicines (United States) United States.; Coles DI; Cancer Research UK Manchester Institute Macclesfield United Kingdom.; Dive C; Cancer Research UK Manchester Institute Cheshire United Kingdom.; Aronchik I; Revolution Medicines (United States) Redwood City, CA United States.; Holderfield M; Revolution Medicines (United States) Redwood City, CA United States.; Lindsay CR; The Christie NHS Foundation Trust Manchester United Kingdom.; Wang Z; Revolution Medicines (United States) Redwood City, CA United States.; Wang Z; Revolution Medicines (United States) Redwood City, CA United States.; Singh M; Revolution Medicines (United States) Redwood City, CA United States.; Smith JAM; Revolution Medicines (United States) Redwood City, CA United States.; Jiang J; Revolution Medicines (United States) Redwood City, CA United States.; Quintana E; Revolution Medicines (United States) Redwood City, CA United States.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Millrine D; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, UK; Cancer Research UK Lung Cancer Centre of Excellence at the University of Manchester, Manchester, UK. Electronic address: David.Millrine@cruk.manchester.ac.uk.; Simpson KL; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, UK; Cancer Research UK Lung Cancer Centre of Excellence at the University of Manchester, Manchester, UK; Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.; Blackhall F; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Medical Oncology, The Christie National Health Service (NHS) Foundation Trust, Manchester, UK.; Dive C; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, UK; Cancer Research UK Lung Cancer Centre of Excellence at the University of Manchester, Manchester, UK; Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK. Electronic address: Caroline.Dive@cruk.manchester.ac.uk.
Publisher: Cell Press Country of Publication: United States NLM ID: 101665956 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-8025 (Electronic) Linking ISSN: 24058025 NLM ISO Abbreviation: Trends Cancer Subsets: MEDLINE
Academic Journal
Vrynas A; Department of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.; Bazban-Shotorbani S; Department of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.; Arfan S; Division of Cancer Biology, The Institute of Cancer Research, London, SM2 5NG, United Kingdom.; Satia K; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, M13 9PL, United Kingdom.; SCLC Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, M20 4BX, United Kingdom.; Cunningham B; Department of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.; Sagindykova G; Department of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.; Ashna M; Department of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.; Zhang A; Department of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.; Visan D; Department of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.; Chen A; Department of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.; Matthews-Palmer T; Division of Structural Biology, The Institute of Cancer Research, London, SW7 3RP, United Kingdom.; Carter M; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, M13 9PL, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, M13 9PL, United Kingdom.; Medical Oncology, Christie Hospital National Health Service Foundation Trust, Manchester, M20 4BX, United Kingdom.; Blackhall F; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, M13 9PL, United Kingdom.; Medical Oncology, Christie Hospital National Health Service Foundation Trust, Manchester, M20 4BX, United Kingdom.; The Division of Cancer Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, M13 9PL, United Kingdom.; Simpson KL; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, M13 9PL, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, M13 9PL, United Kingdom.; SCLC Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, M20 4BX, United Kingdom.; Dive C; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, M13 9PL, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, M13 9PL, United Kingdom.; SCLC Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, M20 4BX, United Kingdom.; Huang P; Division of Cancer Biology, The Institute of Cancer Research, London, SM2 5NG, United Kingdom.; Cancer Research UK Convergence Science Centre, London, SW7 2AZ, United Kingdom.; Au SH; Department of Bioengineering, Imperial College London, London, SW7 2AZ, United Kingdom.; Cancer Research UK Convergence Science Centre, London, SW7 2AZ, United Kingdom.
Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE
Academic Journal
Simpson KL; SCLC Biology Group, Cancer Research UK Manchester Institute, Manchester, UK.; CRUK National Biomarker Centre, University of Manchester, Manchester, UK.; CRUK Lung Cancer Centre of Excellence, Manchester, UK.; Rothwell DG; CRUK National Biomarker Centre, University of Manchester, Manchester, UK.; CRUK Lung Cancer Centre of Excellence, Manchester, UK.; Blackhall F; CRUK Lung Cancer Centre of Excellence, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Medical Oncology, Christie Hospital National Health Service, Foundation Trust, Manchester, UK.; Dive C; SCLC Biology Group, Cancer Research UK Manchester Institute, Manchester, UK. Caroline.Dive@cruk.manchester.ac.uk.; CRUK National Biomarker Centre, University of Manchester, Manchester, UK. Caroline.Dive@cruk.manchester.ac.uk.; CRUK Lung Cancer Centre of Excellence, Manchester, UK. Caroline.Dive@cruk.manchester.ac.uk.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124168 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1768 (Electronic) Linking ISSN: 1474175X NLM ISO Abbreviation: Nat Rev Cancer Subsets: MEDLINE
Academic Journal
Catozzi A; SCLC Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK.; Peiris Pagès M; SCLC Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK.; Humphrey S; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.; Revill M; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.; Morgan D; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.; Roebuck J; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.; Chen Y; SCLC Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK.; Davies-Williams B; SCLC Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK.; Brennan K; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.; Mukarram Hossain ASM; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.; Makeev VJ; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.; Satia K; SCLC Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK.; Sfyri PP; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.; Galvin M; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.; Coles D; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.; Lallo A; SCLC Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK.; Pearce SP; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.; Kerr A; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.; Priest L; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK.; Foy V; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK; Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK.; Carter M; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK; Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK.; Caeser R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Chan JM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Blackhall F; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M20 4BX, UK.; Frese KK; SCLC Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.; Dive C; SCLC Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK. Electronic address: caroline.dive@cruk.manchester.ac.uk.; Simpson KL; SCLC Biology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester and London, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester M20 4BX, UK.
Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
Academic Journal
Behrouzi R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, UK; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, UK; Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.; Clipson A; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, UK.; Simpson KL; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, UK; Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.; Blackhall F; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, UK.; Rothwell DG; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, UK.; Dive C; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, UK; Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.; Mouliere F; Cancer Research UK National Biomarker Centre, University of Manchester, Manchester, UK. Electronic address: f.mouliere@cruk.manchester.ac.uk.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 100966035 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-499X (Electronic) Linking ISSN: 14714914 NLM ISO Abbreviation: Trends Mol Med Subsets: MEDLINE
Academic Journal
Shue YT; Departments of Pediatrics, Stanford University, Stanford, CA, USA.; Departments of Genetics, Stanford University, Stanford, CA, USA.; Drainas AP; Departments of Pediatrics, Stanford University, Stanford, CA, USA.; Departments of Genetics, Stanford University, Stanford, CA, USA.; Li NY; Departments of Program in Epithelial Biology, Stanford University, Stanford, CA, USA.; Pearsall SM; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Morgan D; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Sinnott-Armstrong N; Departments of Genetics, Stanford University, Stanford, CA, USA.; Hipkins SQ; Departments of Pediatrics, Stanford University, Stanford, CA, USA.; Departments of Genetics, Stanford University, Stanford, CA, USA.; Coles GL; Departments of Pediatrics, Stanford University, Stanford, CA, USA.; Departments of Genetics, Stanford University, Stanford, CA, USA.; Lim JS; Departments of Pediatrics, Stanford University, Stanford, CA, USA.; Departments of Genetics, Stanford University, Stanford, CA, USA.; Oro AE; Departments of Program in Epithelial Biology, Stanford University, Stanford, CA, USA.; Simpson KL; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Sage J; Departments of Pediatrics, Stanford University, Stanford, CA, USA. julsage@stanford.edu.; Departments of Genetics, Stanford University, Stanford, CA, USA. julsage@stanford.edu.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Qu F; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Brough SC; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Michno W; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Madubata CJ; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Hartmann GG; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Puno A; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Drainas AP; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Bhattacharya D; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Tomasich E; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Lee MC; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Yang D; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Kim J; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Peiris-Pagès M; Cancer Research UK Cancer Biomarker Centre, Manchester, UK.; Cancer Research UK Manchester Institute, Manchester, UK.; Simpson KL; Cancer Research UK Cancer Biomarker Centre, Manchester, UK.; Cancer Research UK Manchester Institute, Manchester, UK.; Dive C; Cancer Research UK Cancer Biomarker Centre, Manchester, UK.; Cancer Research UK Manchester Institute, Manchester, UK.; Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Toland A; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Kong C; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Das M; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, VA Palo Alto Health Care System, Palo Alto, CA, USA.; Winslow MM; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Pasca AM; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Sage J; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. julsage@stanford.edu.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA. julsage@stanford.edu.
Publisher: Macmillan Magazines Ltd Country of Publication: England NLM ID: 100890575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4679 (Electronic) Linking ISSN: 14657392 NLM ISO Abbreviation: Nat Cell Biol Subsets: MEDLINE
Academic Journal
Pearsall SM; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Williamson SC; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Humphrey S; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Hughes E; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Morgan D; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; García Marqués FJ; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford, California.; Awanis G; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Carroll R; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Burks L; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Shue YT; Department of Pediatrics, Stanford University, Stanford, California; Department of Genetics, Stanford University, Stanford, California.; Bermudez A; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford, California.; Frese KK; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Galvin M; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Carter M; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Priest L; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Kerr A; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Zhou C; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Oliver TG; Department of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina.; Humphries JD; Faculty of Biology Medicine and Health, Wellcome Centre for Cell-Matrix Research, University of Manchester, United Kingdom; Department of Life Sciences, Manchester Metropolitan University, Manchester, United Kingdom.; Humphries MJ; Faculty of Biology Medicine and Health, Wellcome Centre for Cell-Matrix Research, University of Manchester, United Kingdom.; Blackhall F; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom; Division of Cancer Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, United Kingdom; Medical Oncology, Christie Hospital National Health Service (NHS) Foundation Trust, Manchester, United Kingdom.; Cannell IG; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom.; Pitteri SJ; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford, California.; Hannon GJ; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom.; Sage J; Department of Pediatrics, Stanford University, Stanford, California; Department of Genetics, Stanford University, Stanford, California.; Dive C; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom. Electronic address: caroline.dive@cruk.manchester.ac.uk.; Simpson KL; Cancer Research UK Cancer Biomarker Centre, University of Manchester, United Kingdom; Cancer Research UK Manchester Institute, University of Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.
Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Academic Journal
Chemi F; Nucleic Acid Biomarker Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; Pearce SP; Bioinformatics and Biostatistics Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; Clipson A; Nucleic Acid Biomarker Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; Hill SM; Bioinformatics and Biostatistics Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; Conway AM; Nucleic Acid Biomarker Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; The Christie NHS Foundation Trust, Manchester, UK.; Richardson SA; Nucleic Acid Biomarker Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; Kamieniecka K; Bioinformatics and Biostatistics Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; Caeser R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; White DJ; Nucleic Acid Biomarker Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; Mohan S; Nucleic Acid Biomarker Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; Foy V; Nucleic Acid Biomarker Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; The Christie NHS Foundation Trust, Manchester, UK.; Simpson KL; Preclinical and Pharmacology Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; Galvin M; Preclinical and Pharmacology Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; Frese KK; Preclinical and Pharmacology Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; Priest L; Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.; Egger J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Kerr A; Bioinformatics and Biostatistics Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; Massion PP; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Poirier JT; Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA.; Brady G; Nucleic Acid Biomarker Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK.; Blackhall F; The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.; Rothwell DG; Nucleic Acid Biomarker Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK. dominic.rothwell@cruk.manchester.ac.uk.; Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. rudinc@mskcc.org.; Dive C; Nucleic Acid Biomarker Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK. caroline.dive@cruk.manchester.ac.uk.; Bioinformatics and Biostatistics Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK. caroline.dive@cruk.manchester.ac.uk.; Preclinical and Pharmacology Team, Cancer Biomarker Centre, Cancer Research UK Manchester Institute, University of Manchester, Alderley Edge, UK. caroline.dive@cruk.manchester.ac.uk.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Academic Journal
Frizziero M; Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, United Kingdom.; Manchester European Neuroendocrine Tumour Society (ENETS) Centre of Excellence, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Kilgour E; Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, United Kingdom.; Simpson KL; Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, United Kingdom.; Rothwell DG; Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, United Kingdom.; Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, United Kingdom.; Department of Cellular Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; Frese KK; Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, United Kingdom.; Galvin M; Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, United Kingdom.; Lamarca A; Manchester European Neuroendocrine Tumour Society (ENETS) Centre of Excellence, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.; Hubner RA; Manchester European Neuroendocrine Tumour Society (ENETS) Centre of Excellence, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.; Valle JW; Manchester European Neuroendocrine Tumour Society (ENETS) Centre of Excellence, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.; McNamara MG; Manchester European Neuroendocrine Tumour Society (ENETS) Centre of Excellence, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.; Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Payapilly A; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park SK10 4TG, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK.; Guilbert R; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park SK10 4TG, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK.; Descamps T; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK; Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park SK10 4TG, UK.; White G; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park SK10 4TG, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK.; Magee P; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park SK10 4TG, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK.; Zhou C; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK; Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park SK10 4TG, UK.; Kerr A; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK; Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park SK10 4TG, UK.; Simpson KL; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK; Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park SK10 4TG, UK.; Blackhall F; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; Dive C; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK; Cancer Research UK Manchester Institute Cancer Biomarker Centre, The University of Manchester, Alderley Park SK10 4TG, UK.; Malliri A; Cell Signalling Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park SK10 4TG, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK. Electronic address: angeliki.malliri@cruk.manchester.ac.uk.
Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
Academic Journal
Williamson SC; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Metcalf RL; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Trapani F; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Mohan S; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Antonello J; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Abbott B; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Leong HS; Computational Biology Support Team, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Chester CP; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Simms N; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Polanski R; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Nonaka D; The Christie NHS Foundation Trust, Manchester M20 4BX, UK.; Priest L; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Fusi A; The Christie NHS Foundation Trust, Manchester M20 4BX, UK.; Carlsson F; University of Southern California Dornsife, Los Angeles, California 90089-3301, USA.; Carlsson A; University of Southern California Dornsife, Los Angeles, California 90089-3301, USA.; Hendrix MJ; Stanley Manne Children's Research Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.; Seftor RE; Stanley Manne Children's Research Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.; Seftor EA; Stanley Manne Children's Research Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.; Rothwell DG; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Hughes A; The Institute of Cancer Sciences, University of Manchester, Manchester M20 4BX, UK.; Hicks J; University of Southern California Dornsife, Los Angeles, California 90089-3301, USA.; Miller C; RNA Biology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Kuhn P; University of Southern California Dornsife, Los Angeles, California 90089-3301, USA.; Brady G; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Simpson KL; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Blackhall FH; The Christie NHS Foundation Trust, Manchester M20 4BX, UK.; The Institute of Cancer Sciences, University of Manchester, Manchester M20 4BX, UK.; Cancer Research UK, Lung Cancer Centre of Excellence, Manchester M20 4BX, UK.; Dive C; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester M20 4BX, UK.; Cancer Research UK, Lung Cancer Centre of Excellence, Manchester M20 4BX, UK.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Frese KK; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK.; Simpson KL; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK.; Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK. Electronic address: caroline.dive@cruk.manchester.ac.uk.
Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Academic Journal
Pearsall SM; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Humphrey S; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Revill M; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Morgan D; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Frese KK; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Galvin M; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Kerr A; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Carter M; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Priest L; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Blackhall F; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom; Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Simpson KL; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.; Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom; Division of Cancer Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, United Kingdom. Electronic address: Caroline.Dive@manchester.ac.uk.
Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Academic Journal
Simpson KL; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Stoney R; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.; Frese KK; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Simms N; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Rowe W; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Manchester Centre for Synthetic Biology of Fine and Speciality Chemicals (SYNBIOCHEM), Manchester Institute of Biotechnology, The University of Manchester, Manchester, UK.; Pearce SP; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Humphrey S; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Booth L; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Morgan D; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Dynowski M; Scientific Computing Core Facility, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Trapani F; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Catozzi A; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Revill M; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Helps T; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Galvin M; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Girard L; Hamon Center for Therapeutic Oncology Research, Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX, USA.; Nonaka D; The Christie NHS Foundation Trust, Manchester, UK.; Carter L; The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Krebs MG; The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Cook N; The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Carter M; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Priest L; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Kerr A; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK.; Gazdar AF; Hamon Center for Therapeutic Oncology Research, Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX, USA.; Blackhall F; The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK.; Dive C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Manchester, UK. Caroline.Dive@manchester.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, UK. Caroline.Dive@manchester.ac.uk.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Academic Journal
Harrison LR; Clinical and Experimental Pharmacology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, United Kingdom.; Micha DBrandenburg MSimpson KLMorrow CJDenneny OHodgkinson CYunus ZDempsey CRoberts DBlackhall FMakin GDive C
Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Simpson, Kathryn L
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어